Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,896,581
-
Share change
-
-3,567,031
-
Total reported value
-
$31,734,037
-
Put/Call ratio
-
76%
-
Price per share
-
$4.60
-
Number of holders
-
51
-
Value change
-
-$14,683,738
-
Number of buys
-
25
-
Number of sells
-
31
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q3 2017
As of 30 Sep 2017 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,896,581 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Palo Alto Investors, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, and CITADEL ADVISORS LLC.
This table shows 51 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.